Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Cogent Biosciences, Inc. | Chief Commercial Officer | Common Stock | 700 | $5.25K | $7.50 | May 25, 2024 | Direct |
Cogent Biosciences, Inc. | Chief Commercial Officer | Stock Option (Right to Buy) | 525K | May 25, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
COGT | Cogent Biosciences, Inc. | May 25, 2024 | 1 | $0 | 4 | May 29, 2024 | Chief Commercial Officer |
COGT | Cogent Biosciences, Inc. | May 25, 2024 | 0 | $0 | 3 | May 29, 2024 | Chief Commercial Officer |